Skip to main content
. 2024 Dec 18;11(1):e002478. doi: 10.1136/bmjresp-2024-002478

Table 1. Six hypothetical laboratories and their metered dose inhaler-associated carbon footprint and medication cost, per 100 BDR tests.

A B C D E F
Laboratory practice
Actuations per BDR test 2 4 4 12 4 4
Reuse of MDIs Yes Yes Yes Yes No No
Disposal Incineration Incineration Landfill Landfill Incineration Landfill
Consumption (per 100 BDR tests)
MDIs 1 2 2 6 100 100
Actuations 200 400 400 1200 400 400
Medication cost (per 100 BDR tests)
$A $A6.5 $A13 $A13 $A39 $A650 $A650
Carbon footprint in kg CO2e (per 100 BDR tests)
Manufacture 1 2 2 6 100 100
Patient use 25.3 50.7 50.7 152 50.7 50.7
Disposal (propellant) <0.001 <0.001 2.66 7.98 0.26 2607
Disposal (other) 0.015 0.030 0 0 2.9 0
Total kg, CO2e 26.3 52.7 55.4 166 154 2758

The colours in the above table indicate the carbon footprint associated with that particular laboratory practice. Actions with the lowest carbon footprint have green shading, actions with the highest carbon footprint have red shading, while orange indicates an intermediate carbon footprint.

$A, Australian dollars; BDR, bronchodilator responsiveness; CO2e, carbon dioxide equivalent; MDI, metered dose inhaler